Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy

被引：23

作者：

Buyana, Buhle ^{[1
]}

Naki, Tobeka ^{[1
]}

Alven, Sibusiso ^{[1
]}

Aderibigbe, Blessing Atim ^{[1
]}

机构：

[1] Univ Ft Hare, Dept Chem, ZA-5700 Alice, Eastern Cape Pr, South Africa

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2022年 / 23卷 / 19期

基金：

英国医学研究理事会; 新加坡国家研究基金会;

关键词：

colorectal cancer; nanoparticles; platinum; colon; rectum; anticancer drugs; SOLID LIPID NANOPARTICLES; PHASE-II TRIAL; COLON-CANCER; CELLULAR ACCUMULATION; GOLD NANOPARTICLES; FLUOROURACIL-LEUCOVORIN; POLYMERIC NANOPARTICLES; INTRACELLULAR DELIVERY; MULTIDRUG-RESISTANCE; MOLECULAR-MECHANISMS;

D O I：

10.3390/ijms231911261

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Colorectal cancer is a common cancer in both men and women. Numerous studies on the therapeutic effectiveness of nanoparticles against colorectal cancer have been reported. Platinum treatments as well as other medications comprising of nanoparticles have been utilized. Drug resistance restricts the use of platinum medicines, despite their considerable efficacy against a variety of cancers. This review reports clinically licensed platinum medicines (cisplatin, carboplatin, and oxaliplatin) combined with various nanoparticles that have been evaluated for their therapeutic efficacy in the treatment of colorectal cancer, including their mechanism of action, resistance, and limitations.

引用

页数：22

共 184 条

[1]

Abdelwahab H.A., 2021, AlAzhar Journal of Pharmaceutical Sciences, V64, P109

[2] Selective Delivery of Oxaliplatin to Tumor Tissue by Nanocarrier System Enhances Overall Therapeutic Efficacy of the Encapsulated Oxaliplatin [J].

Abu Lila, Amr Selim ;

Kiwada, Hiroshi ;

Ishida, Tatsuhiro .

BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (02) :206-211

[3] Polymer nanoparticles-preparations, applications and future insights: a concise review [J].

Adhikari, Chandan .

POLYMER-PLASTICS TECHNOLOGY AND MATERIALS, 2021, 60 (18) :1996-2024

[4] Ovarian cancer: Strategies for overcoming resistance to chemotherapy [J].

Agarwal, R ;

Kaye, SB .

NATURE REVIEWS CANCER, 2003, 3 (07) :502-516

[5]

Al -Najjar BY, 2020, SYS REV PHARM, V11, P1152

[6] Oral and Intra-nasal Administration of Nanoparticles in the Cerebral Ischemia Treatment in Animal Experiments: Considering its Advantages and Disadvantages open access plus [J].

Alavian, Firoozeh ;

Shams, Nasrin .

CURRENT CLINICAL PHARMACOLOGY, 2020, 15 (01) :20-29

[7] Voltage-Gated Sodium Channel Polymorphisms Play a Pivotal Role in the Development of Oxaliplatin-Induced Peripheral Neurotoxicity Results From a Prospective Multicenter Study [J].

Argyriou, Andreas A. ;

Cavaletti, Guido ;

Antonacopoulou, Anna ;

Genazzani, Armando A. ;

Briani, Chiara ;

Bruna, Jordi ;

Terrazzino, Salvatore ;

Velasco, Roser ;

Alberti, Paola ;

Campagnolo, Marta ;

Lonardi, Sara ;

Cortinovis, Diego ;

Cazzaniga, Marina ;

Santos, Cristina ;

Psaromyalou, Aikaterini ;

Angelopoulou, Aikaterini ;

Kalofonos, Haralabos P. .

CANCER, 2013, 119 (19) :3570-3577

[8] A PHASE-II STUDY OF CARBOPLATIN AND CHIP IN PATIENTS WITH METASTATIC COLON-CARCINOMA [J].

ASBURY, RF ;

KRAMER, A ;

GREEN, M ;

QAZI, R ;

SKEEL, RT ;

HALLER, DG .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (05) :416-419

[9] Nanoparticles in Cancer Chemotherapy [J].

Banerjee, Deboshri ;

Sengupta, Shiladitya .

NANOPARTICLES IN TRANSLATIONAL SCIENCE AND MEDICINE, 2011, 104 :489-507

[10] Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors [J].

Batist, Gerald ;

Gelmon, Karen A. ;

Chi, Kim N. ;

Miller, Wilson H., Jr. ;

Chia, Stephen K. L. ;

Mayer, Lawrence D. ;

Swenson, Christine E. ;

Janoff, Andrew S. ;

Louie, Arthur C. .

CLINICAL CANCER RESEARCH, 2009, 15 (02) :692-700

← 1 2 3 4 5 6 7 8 9 10 →